Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The response rate was nearly 50% for people with breast, colon, pancreatic and other cancers.
Here are latest cancer drugs approved by the Food and Drug Administration.
More than 80% of lung cancer patients treated with the targeted therapy experienced remission or had stable disease.
The targeted therapy delayed disease progression in people with advance non-small-cell lung cancer, including those with brain metastasis.
The checkpoint inhibitor delayed disease progression and improved overall survival in non-small-cell lung cancer patients.
“Saved By the Bell” actor Dustin Diamond died Monday at age 44 from small cell lung cancer.
The new targeted therapy was approved for non-small-cell lung cancer with a specific MET mutation.
The decrease is largely due to improved lung cancer treatment, but the impact of COVID-19 is not yet known.
Tagrisso (osimertinib) was approved for non-small cell lung cancer patients with EGFR-positive tumors.
New targeted therapies and immunotherapies can lead to better treatment outcomes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.